Valuation: Nexentis Technologies Inc.

Market Cap 1.08M 950K 887K 814K 1.52M 104M 1.56M 10.51M 4.11M 51.24M 4.06M 3.97M 177M P/E 2024
-0.28x
P/E 2025 -0.34x
Enterprise Value -2M -1.76M -1.64M -1.5M -2.82M -191M -2.88M -19.43M -7.6M -94.7M -7.5M -7.34M -327M EV / Sales 2024
1.64x
EV / Sales 2025 -
Free-Float
78.83%
Yield 2024 *
-
Yield 2025 -
1 day-4.52%
1 week-28.16%
Current month-65.66%
1 month-68.31%
3 months-68.51%
6 months-83.22%
Current year-87.41%
1 week 1.43
Extreme 1.4301
1.94
1 month 1.43
Extreme 1.4301
4.55
Current year 1.43
Extreme 1.4301
23.8
1 year 1.43
Extreme 1.4301
61.74
3 years 1.43
Extreme 1.4301
4,047.41
5 years 1.43
Extreme 1.4301
16,995.68
10 years 1.43
Extreme 1.4301
54,022.91
Manager TitleAgeSince
Chief Executive Officer 60 2020-11-04
Director of Finance/CFO 39 2022-04-17
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 53 2020-08-25
Chairman 62 2021-05-23
Director/Board Member 54 2020-08-25
Date Insider Type Main position Quantity % Market Cap.
2/9/26 Free

Chief Financial Officer

50,000 1.8639%
2/9/26 Free

Chief Executive Officer

100,000 3.7279%
2/9/26 Free

Chairman

116,286 4.3350%
Change 5-day change 1-year change 3-year change Capi.($)
-4.52%-28.16%-97.52%-99.84% 1.08M
+1.75%+2.24%+24.19%+61.22% 60.53B
+0.11%-.--%-.--%-.--% 12.96B
+2.36%-2.07%+23.68%+167.36% 10.69B
+1.67%+0.98%+21.95%+61.31% 8.05B
-2.67%-4.14%-23.65%-23.77% 6.58B
-1.34%+1.20%-15.32%+71.87% 5.58B
-1.25%-0.79%-16.63%-3.59% 5.37B
+0.54%+1.94%+23.98%+33.92% 4.81B
+1.01%+1.44%-35.68%-23.13% 4.36B
Average -0.23%-1.99%-9.50%+24.54% 11.89B
Weighted average by Cap. +1.02%+1.35%+12.81%+52.76%

Financials

2024 2025
Net sales 210K 185K 172K 158K 296K 20.11M 303K 2.04M 799K 9.95M 788K 771K 34.41M -
Net income -5.19M -4.56M -4.26M -3.91M -7.32M -497M -7.5M -50.51M -19.75M -246M -19.5M -19.07M -851M -4M -3.52M -3.28M -3.01M -5.64M -384M -5.78M -38.94M -15.23M -190M -15.03M -14.71M -656M
Net Debt -2.48M -2.18M -2.04M -1.87M -3.5M -238M -3.59M -24.17M -9.45M -118M -9.33M -9.13M -407M -3.08M -2.71M -2.53M -2.32M -4.34M -295M -4.45M -29.95M -11.71M -146M -11.56M -11.31M -505M
Logo Nexentis Technologies Inc.
Nexentis Technologies Inc, formerly known as N2OFF, Inc., is an AI and data-driven computational biotech platform focused on mitochondrial biology, precision oncology and inflammatory metabolic diseases. Through its subsidiary MitoCareX Bio Ltd. The company uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. It enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.
Employees
8
Date Price Change Volume
26-07-29 US$1.480 -4.52% 51,126
26-07-28 US$1.550 -7.19% 610,502
26-07-27 US$1.670 -7.22% 34,014
26-07-24 US$1.800 -5.76% 18,970
26-07-23 US$1.910 -7.28% 51,275
  1. Stock Market
  2. Stocks
  3. NXTS Stock